Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: ISICC-applied prediction model
Prediction of overall survival in resectable intrahepatic cholangiocarcinoma: ISICC-applied prediction model
复制标题
可切除肝内胆管癌总生存率的预测:IS(ICC) 应用预测模型。
DOI:
10.1111/cas.14315
复制
发表时间:
2020-02-12
期刊:
影响因子:
5.7
通讯作者:
Shi, Yinghong
中科院分区:
文献类型:
--
作者:
Tian, Mengxin;Liu, Weiren;Shi, Yinghong
Intrahepatic cholangiocarcinoma (ICC) remains a highly heterogeneous disease with poor prognosis. Tumor-infiltrating lymphocytes were predictive in various cancers, but their prognostic value in ICC is less clear. A total of 168 ICC patients who had received liver resection were enrolled and assigned to the derivation cohort. Sixteen immune markers in tumor and peritumor regions were examined by immunohistochemistry. A least absolute shrinkage and selection operator model was used to identify prognostic markers and to establish an immune signature for ICC (ISICC). An ISICC-applied prediction model was built and validated in another independent dataset. Five immune features, including CD3(peritumor (P)), CD57(P), CD45RA(P), CD66b(intratumoral (T)) and PD-L1(P), were identified and integrated into an individualized ISICC for each patient. Seven prognostic predictors, including total bilirubin, tumor numbers, CEA, CA19-9, GGT, HBsAg and ISICC, were integrated into the final model. The C-index of the ISICC-applied prediction model was 0.719 (95% CI, 0.660-0.777) in the derivation cohort and 0.667 (95% CI, 0.581-0.732) in the validation cohort. Compared with the conventional staging systems, the new model presented better homogeneity and a lower Akaike information criteria value in ICC. The ISICC-applied prediction model may provide a better prediction performance for the overall survival of patients with resectable ICC in clinical practice.